The global pulmonary/respiratory drug delivery market reached $40.67 bn in 2018 and is expected to grow at a CAGR of 7.60% in 2019-2024. The MDIs segment is estimated to hold a share of 62.4% in 2018. Increasing prevalence and incidence of chronic respiratory diseases is a major factor that is expected to drive the growth of this market.
How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 155-page report you will receive 70 tables and 84 figures– all unavailable elsewhere.
The 155-page report provides clear detailed insight into the global pulmonary/respiratory drug delivery market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand-new report today you stay better informed and ready to act.
Report Scope
• Global Pulmonary/Respiratory Drug Delivery Market forecasts from 2019-2029
• Global Pulmonary/Respiratory Drug Delivery Market forecasts from 2019-2029 by Product:
– Formulation: Suspension Aerosol. Solution Aerosol, Dry Powder Formulation
– Devices: Metered Dose Inhalers (MDIS), Dry Powder Inhalers (DPIS), Nebulizers, Accessories
• Global Pulmonary/Respiratory Drug Delivery Market forecasts from 2019-2029 by Canister Type:
– Plain Canisters
– Coated Canister
• Global Pulmonary/Respiratory Drug Delivery Market forecasts from 2019-2029 by Application:
– Asthma
– COPD
– Cystic Fibrosis
– Other Applications
• Global Pulmonary/Respiratory Drug Delivery Market forecasts from 2019-2029 by End-User:
– Hospitals & Clinics
– Homecare Settings
• Global Pulmonary/Respiratory Drug Delivery Market forecasts from 2018-2029 by regional and national market:
– North America (US, Canada)
– Europe (Germany, UK, France, Italy, Spain)
– Asia-Pacific (Japan, China, India, Australia, Malaysia)
– RoW (Brazil, Mexico, Turkey, South Africa, Argentina)
• Profiles of the selected leading companies:
– 3M Health Care
– AstraZeneca
– Boehringer Ingelheim GmbH
– GlaxoSmithKline PLC
– Merck & Co., Inc.
– Novartis AG
– OMRON Corporation
– Philips Respironics
– Sunovion Pharmaceuticals Inc.
– Teva Pharmaceutical
• Qualitative analysis of the global pulmonary/respiratory drug delivery market. Discussion on trends, factors that drive and restrain the market as well as Porter’s Five Forces Analysis.
• Key Questions Answered by this Report:
– What are the global revenue prospects for the period 2018 to 2029?
– What are the leading national market potentials from 2018 to 2029?
– How is the respiratory drug delivery market evolving?
– What is driving and restraining the respiratory drug delivery market?
– What are the market shares of each segment of the overall respiratory drug delivery market?
– How will main respiratory drug delivery submarket segments develop over the forecast period and how much revenue will these submarkets account for in 2029?
– How will the market shares for each respiratory drug delivery submarket develop from 2018 to 2029?
– What will be the main commercial drivers for the market from 2018 to 2029?
– How will political and regulatory factors influence that industry and its submarkets?
– How will market shares of prominent national markets change from 2018, and which countries will lead the market in 2029, achieving highest revenues and fastest growth?
Visiongain’s study is intended for anyone requiring commercial analyses for the Global Pulmonary/Respiratory Drug Delivery Market. You find data, trends and predictions.
Buy our report today Global Pulmonary/Respiratory Drug Delivery Market analysis: Suspension Aerosol, Solution Aerosol, Dry Powder Formulation, Metered Dose Inhalers (MDIS), Dry Powder Inhalers (DPIS), Nebulizers, Accessories, Plain Canister, Coated Canister, Asthma, COPD, Cystic Fibrosis, Other Applications, Hospitals & Clinics, Homecare Settings.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1 Global Respiratory Drug Delivery Market Overview
1.2 Global Respiratory Drug Delivery Market Segmentation
1.3 Overview of Findings
1.4 Structure of the Report
1.5 Why You Should Read This Report
1.6 Key Questions Answered by This Analytical Report
1.7 Who is This Report For?
1.8 Methods of the Study
1.9 Frequently Asked Questions (FAQ)
1.10 Associated Visiongain Reports
1.11 About Visiongain
2. Introduction to Respiratory Drug Delivery
2.1 What is Respiratory Drug Delivery?
2.2 The Role and Function of Pulmonary/Respiratory Drug Delivery
2.3 Advantages of Respiratory Drug Delivery
2.4 Disadvantages of Respiratory Drug Delivery
2.5 Type of Respiratory Drug Delivery Devices
2.5.1 Metered Dose Inhalers (MDI)
2.5.2 Dry Powder Inhalers
2.5.3 Nebulizer
2.6 Mechanisms of Pulmonary Drug Administration
2.7 Prevalence of Respiratory Diseases?
3. Respiratory Drug Delivery: World Market 2019-2029
3.1 Respiratory Drug Delivery Market Overview, 2018
3.2 The World Respiratory Drug Delivery Market
3.3 World Respiratory Drug Delivery Market: Sales Forecast 2019-2029
3.4 Changing Market Shares by Region 2018-2029
4. Respiratory Drug Delivery: Qualitative Analysis 2019-2029
4.1 Respiratory Drug Delivery Market: Drivers 2019-2029
4.1.1 Increase in Prevalence and Incidence of Respiratory Diseases
4.1.2 Technological Advancements
4.1.3 Growing Support of Government and NGOs for Respiratory Diseases Healthcare Awareness
4.2 Respiratory Drug Delivery Market Restraints: 2019-2029
4.2.1 Stringent Government Regulations
4.2.2 Intense Competition Among Vendors
4.3 Respiratory Drug Delivery Market Trends: 2019-2029
4.3.1 Introduction of Smart/Digital Inhalers
4.3.2 Recent Advances in Pulmonary Drug Delivery
4.3.3 Trends in MDI Technology
4.3.4 Trends in DPI Technology
4.4 Respiratory Drug Delivery Market: Porters Five Forces Analysis, 2019-2029
4.4.1 Bargaining Power of Supplier: Moderate
4.4.2 Bargaining Power of Buyer: Moderate
4.4.3 Competitive Rivalry: High
4.4.4 The Threat of New Entrants: Moderate
4.4.5 Threat of Substitutes: Moderate
5. Respiratory Drug Delivery Market by Product, 2019-2029
5.1 Market Overview
5.2 Global Respiratory Drug Delivery Market Forecast by Product, 2019-2029
5.3 Market Share of Respiratory Drug Delivery by Product
5.3.1 Formulation: Market Forecast, 2019-2029
5.3.2 Suspension Aerosol: Market Forecast, 2019-2029
5.3.3 Solution Aerosol: Market Forecast, 2019-2029
5.3.4 Dry Powder Formulation: Market Forecast, 2018-2029
5.3.5 Devices: Market Forecast, 2018-2029
5.3.6 Metered Dose Inhalers (MDIs): Market Forecast, 2019-2029
5.3.7 Dry Powder Inhalers (DPIs): Market Forecast, 2019-2029
5.3.8 Nebulizers: Market Forecast, 2019-2029
5.3.9 Accessories: Market Forecast, 2019-2029
6. Respiratory Drug Delivery Market by Canister Type, 2019-2029
6.1 Global Respiratory Drug Delivery Market Forecast by Canister Type, 2019-2029
6.2 Market Forecast 2019-2029
6.3 Plain Canisters Market
6.4 Coated Canister Market
7. Respiratory Drug Delivery Market by Application, 2019-2029
7.1 Global Respiratory Drug Delivery Market Forecast by Application, 2019-2029
7.2 Market Forecast 2019-2029
7.3 Asthma Market
7.4 Chronic Obstructive Pulmonary Disease (COPD) Market
7.5 Cystic Fibrosis Market
7.6 Other Applications Market
8. Respiratory Drug Delivery Market by End-User 2019-2029
8.1 Market Overview
8.2 Global Respiratory Drug Delivery Market Forecast by End-User, 2019-2029
8.3 Market Share of Respiratory Drug Delivery by End-User
8.4 Hospitals & Clinics Market
8.5 Homecare Settings Market
9. Leading National Markets 2019-2029
9.1 Geographical Breakdown of the World Respiratory Drug Delivery Market
9.2 Global Respiratory Drug Delivery Market: Regional Forecast 2019-2029
9.3 How Will Regional Market Shares Change to 2029?
9.4 North America Respiratory Drug Delivery Market, 2019-2029
9.4.1 US Respiratory Drug Delivery Market Forecast 2019-2029
9.4.2 Canada Respiratory Drug Delivery Market Forecast 2019-2029
9.5 Europe Respiratory Drug Delivery Market, 2019-2029
9.5.1 Europe Respiratory Drug Delivery Market Forecast 2019-2029
9.5.2 Germany Respiratory Drug Delivery Market Forecast 2019-2029
9.5.3 UK Respiratory Drug Delivery Market Forecast 2019-2029
9.5.4 French Respiratory Drug Delivery Market Forecast 2019-2029
9.5.5 Italian Respiratory Drug Delivery Market Forecast 2019-2029
9.5.6 Spanish Respiratory Drug Delivery Market Forecast 2019-2029
9.6 Asia-Pacific Respiratory Drug Delivery Market 2019-2029
9.6.1 Japanese Respiratory Drug Delivery Market Forecast 2019-2029
9.6.2 Chinese Respiratory Drug Delivery Market 2019-2029
9.6.3 Indian Respiratory Drug Delivery Market 2019-2029
9.6.4 Australia Respiratory Drug Delivery Market Forecast 2019-2029
9.6.5 Malaysia Respiratory Drug Delivery Market Forecast 2019-2029
9.7 RoW Respiratory Drug Delivery Market 2019-2029
9.7.1 Brazilian Respiratory Drug Delivery Market Forecast 2019-2029
9.7.2 Mexico Respiratory Drug Delivery Market 2019-2029
9.7.3 Turkey Respiratory Drug Delivery Market Forecast 2019-2029
9.7.4 South Africa Respiratory Drug Delivery Market Forecast 2019-2029
9.7.5 Argentina Respiratory Drug Delivery Market Forecast 2019-2029
10. Leading Companies in the Respiratory Drug Delivery Market
10.1 GlaxoSmithKline PLC
10.1.1 Product Portfolio
10.1.2 Financial Overview
10.2 Philips Respironics
10.2.1 Product Portfolio
10.2.2 Financial Overview
10.3 Boehringer Ingelheim GmbH
10.3.1 Products Portfolio
10.3.2 Financial Overview
10.3.3 Recent Developments
10.4 3M Health Care
10.4.1 Product Portfolio
10.4.1 Financial Overview
10.5 AstraZeneca plc
10.5.1 Product Portfolio
10.5.2 Financial Overview
10.5.3 Recent Developments
10.6 Merck & Co., Inc.
10.6.1 Product Portfolio
10.6.2 Financial Overview
10.7 Novartis AG
10.7.1 Products Portfolio
10.7.2 Financial Overview
10.7.3 Recent Developments
10.8 Omron Corporation
10.8.1 Product Portfolio
10.8.2 Financial Overview
10.9 Sunovion Pharmaceuticals Inc.
10.9.1 Product Portfolio
10.9.2 Financial Overview
10.9.3 Recent Developments
10.10 Teva Pharmaceuticals
10.10.1 Product Portfolio
10.10.2 Financial Overview
10.10.3 Recent Developments
10.11 Other Prominent Players in the Market
11. Conclusion
11.1 Outlook for Pulmonary/respiratory drug delivery Market
11.2 Key Findings
Appendices
Associated Visiongain Reports
Visiongain Report Sales Order Form
About Visiongain
Visiongain Report Evaluation Form
List of Tables
Table 3.1 Global Respiratory Drug Delivery Market Forecast Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 5.1 Global Respiratory Drug Delivery Market Forecast by Product: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 5.2 Global Formulation Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2018-2029
Table 5.3 Global Suspension Aerosol Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2018-2029
Table 5.4 Global Solution Aerosol Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2018-2029
Table 5.5 Global Dry Powder Formulation Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2018-2029
Table 5.6 Global Respiratory Drug Delivery Devices Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2018-2029
Table 5.7 Global Metered Dose Inhalers (MDIs) Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2018-2029
Table 5.8 Global Dry Powder Inhalers (DPIs) Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2018-2029
Table 5.9 Global Nebulizers Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2018-2029
Table 5.10 Global Jet Nebulizers Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2018-2029
Table 5.11 Global Ultrasonic Nebulizers Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2018-2029
Table 5.12 Global Soft Mist Nebulizers Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2018-2029
Table 5.13 Global Accessories Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2018-2029
Table 6.1 Global Respiratory Drug Delivery Market Forecast by Canister Type: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 6.2 Global Plain Canisters Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2018-2029
Table 6.3 Global Coated Canisters Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2018-2029
Table 7.1 Global Respiratory Drug Delivery Market Forecast by Application: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 7.2 Global Asthma Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2018-2029
Table 7.3 Global COPD Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2018-2029
Table 7.4 Global Cystic Fibrosis Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2018-2029
Table 7.5 Global Other Applications Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2018-2029
Table 8.1 Global Respiratory Drug Delivery Market Forecast by End-User: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 8.2 Global Hospitals & Clinics Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2018-2029
Table 8.3 Global Homecare Settings Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2018-2029
Table 9.1 World Respiratory Drug Delivery Market by Region: Revenue ($bn) and Market Share (%) 2018 and 2029
Table 9.2 Global Respiratory Drug Delivery Market Forecast by Region: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 9.3 North America Respiratory Drug Delivery Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 9.4 North America Respiratory Drug Delivery Market by Region Forecast: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 9.5 US Respiratory Drug Delivery Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 9.6 Canada Respiratory Drug Delivery Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 9.7 Europe Respiratory Drug Delivery Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 9.8 Europe Respiratory Drug Delivery Market Forecast by Country: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 9.9 Germany Respiratory Drug Delivery Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 9.10 UK Respiratory Drug Delivery Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 9.11 French Respiratory Drug Delivery Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 9.12 Italian Respiratory Drug Delivery Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 9.13 Spanish Respiratory Drug Delivery Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 9.14 Asia-Pacific Respiratory Drug Delivery Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 9.15 Asia-Pacific Respiratory Drug Delivery Market Forecast by Country: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 9.16 Japanese Respiratory Drug Delivery Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 9.17 Chinese Respiratory Drug Delivery Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 9.18 Indian Respiratory Drug Delivery Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 9.19 Australia Respiratory Drug Delivery Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 9.20 Malaysia Respiratory Drug Delivery Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 9.21 Brazilian Respiratory Drug Delivery Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 9.22 Mexico Respiratory Drug Delivery Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 9.23 Turkey Respiratory Drug Delivery Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 9.24 South Africa Respiratory Drug Delivery Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 9.25 Argentina Respiratory Drug Delivery Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 10.1 Overview: GlaxoSmithKline plc.
Table 10.2 Product Portfolio: GlaxoSmithKline plc.
Table 10.3 Overview: Philips Respironics
Table 10.4 Product Portfolio: Philips Respironics
Table 10.5 Overview: Boehringer Ingelheim GmbH
Table 10.6 Product Portfolio: Boehringer Ingelheim GmbH
Table 10.7 Overview: 3M Health Care
Table 10.8 Product Portfolio: 3M Health Care
Table 10.9 Overview: AstraZeneca plc
Table 10.10 Product Portfolio: AstraZeneca
Table 10.11 Overview: Merck & Co., Inc
Table 10.12 Product Portfolio: Merck & Co., Inc
Table 10.13 Overview: Novartis
Table 10.14 Product Portfolio: Novartis
Table 10.15 Overview: OMRON Corporation
Table 10.16 Product Portfolio: Omron Corporation
Table 10.17 Overview: Sunovion Pharmaceuticals
Table 10.18 Product Portfolio: Sunovion Pharmaceuticals Inc.
Table 10.19 Overview: Teva Pharmaceuticals
Table 10.20 Product Portfolio: Teva Pharmaceuticals
List of Figures
Figure 1.1 Global Respiratory Drug Delivery Market Segmentation Overview, 2018
Figure 2.1 Types of Respiratory Drug Delivery Devices, 2018
Figure 3.1 Global Respiratory Drug Delivery Market Forecast Revenue ($bn), AGR (%) 2018-2029
Figure 3.2 Global Respiratory Drug Delivery Market Forecast Share (%) by Region 2018-2029
Figure 4.1 Respiratory Drug Delivery Market: Drivers 2019-2029
Figure 4.2 Respiratory Drug Delivery Market: Restraints 2019-2029
Figure 4.3 Respiratory Drug Delivery Market: Trends 2019-2029
Figure 5.1 Global Respiratory Drug Delivery Market Forecast by Product: Revenue ($bn) 2018-2029
Figure 5.2 Global Respiratory Drug Delivery Market Forecast by Product: Market Share (%) 2018-2029
Figure 5.3 Global Respiratory Drug Delivery Market Forecast by Product: Market Shares (%), 2018
Figure 5.4 Global Respiratory Drug Delivery Market Forecast by Product: Market Shares (%), 2024
Figure 5.5 Global Respiratory Drug Delivery Market Forecast by Product: Market Shares (%), 2029
Figure 5.6 Global Formulation Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
Figure 5.7 Global Suspension Aerosol Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
Figure 5.8 Global Solution Aerosol Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
Figure 5.9 Global Dry Powder Formulation Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
Figure 5.10 Global Respiratory Drug Delivery Devices Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
Figure 5.11 Global Metered Dose Inhalers (MDIs) Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
Figure 5.12 Global Dry Powder Inhalers (DPIs) Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
Figure 5.13 Global Nebulizers Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
Figure 5.14 Global Jet Nebulizers Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
Figure 5.15 Global Ultrasonic Nebulizers Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
Figure 5.16 Global Soft Mist Nebulizers Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
Figure 5.17 Global Accessories Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
Figure 6.1 Global Respiratory Drug Delivery Market Forecast by Canister Type: Revenue ($bn) 2018-2029
Figure 6.2 Global Respiratory Drug Delivery Market Forecast by Canister Type: Market Share (%) 2018-2029
Figure 6.3 Global Respiratory Drug Delivery Market by Canister Type: Market Shares (%), 2018
Figure 6.4 Global Respiratory Drug Delivery Market by Canister Type: Market Shares (%), 2024
Figure 6.5 Global Respiratory Drug Delivery Market by Canister Type: Market Shares (%), 2029
Figure 6.6 Global Plain Canisters Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
Figure 6.7 Global Coated Canisters Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
Figure 7.1 Global Respiratory Drug Delivery Market Forecast by Application: Revenue ($bn) 2018-2029
Figure 7.2 Global Respiratory Drug Delivery Market Forecast by Application: Market Share (%) 2018-2029
Figure 7.3 Global Respiratory Drug Delivery Market by Application: Market Shares (%), 2018
Figure 7.4 Global Respiratory Drug Delivery Market by Application: Market Shares (%), 2024
Figure 7.5 Global Respiratory Drug Delivery Market by Application: Market Shares (%), 2029
Figure 7.6 Global Asthma Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
Figure 7.7 Global COPD Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
Figure 7.8 Global Cystic Fibrosis Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
Figure 7.9 Global Other Applications Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
Figure 8.1 Global Respiratory Drug Delivery Market Forecast by End-User Market Revenue ($bn) 2018-2029
Figure 8.2 Global Respiratory Drug Delivery Market Forecast by End-User Market Share (%) 2018-2029
Figure 8.3 Global Respiratory Drug Delivery Market Forecast by End-User: Market Shares (%), 2018
Figure 8.4 Global Respiratory Drug Delivery Market Forecast by End-User: Market Shares (%), 2024
Figure 8.5 Global Respiratory Drug Delivery Market Forecast by End-User: Market Shares (%), 2029
Figure 8.6 Global Hospitals & Clinics Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
Figure 8.7 Global Homecare Settings Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
Figure 9.1 Global Respiratory Drug Delivery Market by Region: Revenues (%), 2018
Figure 9.2 Global Respiratory Drug Delivery Market by Region: Revenues (%), 2024
Figure 9.3 Global Respiratory Drug Delivery Market by Region: Revenues (%), 2029
Figure 9.4 North America Respiratory Drug Delivery Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
Figure 9.5 North America Respiratory Drug Delivery Market by Region Forecast: Market Share (%), 2018-2029
Figure 9.6 US Respiratory Drug Delivery Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
Figure 9.7 Canada Respiratory Drug Delivery Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
Figure 9.8 Europe Respiratory Drug Delivery Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
Figure 9.9 Europe Respiratory Drug Delivery Market by Country: Revenue ($bn), 2018-2029
Figure 9.10 Europe Respiratory Drug Delivery Market by Country: Share (%), 2018-2029
Figure 9.11 Germany Respiratory Drug Delivery Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
Figure 9.12 UK Respiratory Drug Delivery Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
Figure 9.13 French Respiratory Drug Delivery Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
Figure 9.14 Italian Respiratory Drug Delivery Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
Figure 9.15 Spanish Respiratory Drug Delivery Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
Figure 9.16 Asia-Pacific Respiratory Drug Delivery Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
Figure 9.17 Asia-Pacific Respiratory Drug Delivery Market by Country: Revenue ($bn), 2018-2029
Figure 9.18 Asia Pacific Respiratory Drug Delivery Market by Country: Share (%), 2018-2029
Figure 9.19 Japanese Respiratory Drug Delivery Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
Figure 9.20 Chinese Respiratory Drug Delivery Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
Figure 9.21 Indian Respiratory Drug Delivery Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
Figure 9.22 Australia Respiratory Drug Delivery Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
Figure 9.23 Malaysia Respiratory Drug Delivery Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
Figure 9.24 Brazilian Respiratory Drug Delivery Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
Figure 9.25 Mexico Respiratory Drug Delivery Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
Figure 9.26 Turkey Respiratory Drug Delivery Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
Figure 9.27 South Africa Respiratory Drug Delivery Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
Figure 9.28 Argentina Respiratory Drug Delivery Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
Figure 10.1 GlaxoSmithKline plc.: Financial Overview, 2016-2018
Figure 10.2 Boehringer Ingelheim GmbH: Financial Overview: 2016-2018
Figure 10.3 3M Health Care Financial Overview:2018
Figure 10.4 AstraZeneca plc: Financial Overview 2016- 2018
Figure 10.5 Merck & Co., Inc: Financial Overview 2016-2018
Figure 10.6 Novartis: Financial Overview 2016-2018
Figure 10.7 OMRON Corporation: Financial Overview 2016-2018
Figure 11.1 Global Respiratory Drug Delivery Market Forecast Revenue ($bn), AGR (%) 2018-2029
Figure 11.2 Global Respiratory Drug Delivery Market Forecast Share (%) by Region 2018-2029
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
